Study Identifies Heart Risks in Glaxo’s Avandia

Airtime: Mon. Feb. 22 2010 | ET

Dr. Steven Nissen, of the Cleveland Clinic, authored a controversial study identifying heart risks in GlaxoSmithKline’s Avandia diabetes drug. He talks to CNBC’s Mike Huckman.

If you enjoyed this post, make sure you subscribe to my RSS feed!
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *